RDHLRedHill Biopharma Ltd.同业对比
RedHill Biopharma Ltd. 与SIC 2834 行业的逐项对比:市值、估值、增长、盈利能力、质量与总回报,以及在同业组内的排名。所有数值均由引擎从 SEC 申报与延迟行情计算,排名仅为组内排序位置 —— 描述性数据,非投资建议。
完整同业对比
同业组:同 SIC 行业分类 | 公司 | 市值 | 市盈率(TTM) | 市净率 | 市销率 | 营收同比增长 | 净利同比增长 | 息税前利润率 | 净资产收益率 | 投入资本回报率 | 皮氏 F 值 | 一年总回报 | 股息率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| RDHL本股 | $23.2B#1 | — | — | 2883.9x#6 | 23.2%#4 | -134.6%#11 | -181.7%#5 | — | — | — | -64.4%#6 | — |
| QNRX | $296M#5 | — | 75.3x#5 | — | — | -75.6%#8 | — | -401.8%#7 | — | — | -61.6%#5 | — |
| QNTM | $27#8 | — | — | — | — | — | — | — | — | — | — | — |
| QUCY | $61M#7 | — | 3.0x#2 | 113.8x#4 | -39.9%#10 | 24.9%#1 | -3005.0%#10 | -79.6%#5 | -203.8%#3 | — | — | — |
| QURE | $1.5B#4 | — | 10.1x#4 | 93.6x#3 | -40.6%#11 | 16.9%#4 | -1151.4%#8 | -133.3%#6 | -263.3%#4 | — | -30.1%#4 | — |
| RADX | $3.2B#3 | — | — | 868.2x#5 | 1114.3%#1 | 20.0%#2 | -1050.6%#6 | — | — | — | -83.2%#8 | — |
| RANI | $99M#6 | — | 2.5x#1 | 60.8x#2 | 58.9%#3 | 1.1%#7 | -2346.0%#9 | -75.6%#4 | — | — | -74.5%#7 | — |
| RDPTF | — | — | — | — | 1114.3%#1 | 20.0%#2 | -1050.6%#6 | — | — | — | — | — |
| RDY | $11.9B#2 | — | 3.1x#3 | 3.1x#1 | 13.8%#5 | — | 22.1%#2 | 17.0%#1 | — | — | 7.5%#2 | 0.7%#1 |
| REGN | — | 21.5x#1 | — | — | 1.0%#6 | 2.1%#6 | 24.9%#1 | 13.4%#2 | 9.2%#1 | — | 51.7%#1 | — |
| RFL | — | — | — | — | -4.7%#9 | 2.9%#5 | -3822.5%#11 | -44.7%#3 | -50.5%#2 | — | -15.3%#3 | — |
| RGBP | — | — | — | — | 0.0%#7 | -90.7%#9 | -143.1%#3 | — | — | — | — | — |
| RGBPP | — | — | — | — | 0.0%#7 | -90.7%#9 | -143.1%#3 | — | — | — | — | — |
数值来自 SEC 申报与延迟行情;排名仅为该组内的排序位置 —— 描述性数据,不构成评级或建议。 本表构建超时,仅覆盖该组的一部分成员;排名仅相对于已列出的行,稍后会自动补全。 数据构建于 2026-11-04。
数据来自 SEC XBRL 申报与延迟行情 · 排名为组内排序 · 仅供参考 · 非投资建议